ArticleBMJ open2022

Prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-up.

Niels Adriaenssens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.